Rare diseases: specific challenges for sustainable accessibility of treatments for patients
Rare Disease and Orphan Drugs Journal · 2022
DOI: 10.20517/rdodj.2022.08 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, 2022. Verfasst von Lucas Cortial und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
In late 2021, the health technology assessment of the French National Authority for Health was seized by the French Ministry of Solidarity and Health to address a specific challenge, the identification of solutions contributing to the development of the methodological expertise in new types of clinical studies for rare diseases. Experts from the rare diseases environment were gathered by OrphanDev, the French network of expertise dedicated to rare diseases. They allowed to identify some of the current issues in France concerning rare diseases, and then present different solutions, in particular related to the evaluation process of orphan drugs and the collection of data on rare diseases.
Zitieren
APA
Cortial, L., Boyer, P., Forget, S., Joubioux, R. L., Blin, O., & Mouthon, F. (2022). Rare diseases: specific challenges for sustainable accessibility of treatments for patients. Rare Disease and Orphan Drugs Journal. https://doi.org/10.20517/rdodj.2022.08
Vancouver
Cortial L, Boyer P, Forget S, Joubioux RL, Blin O, Mouthon F. Rare diseases: specific challenges for sustainable accessibility of treatments for patients. Rare Disease and Orphan Drugs Journal. 2022. doi:10.20517/rdodj.2022.08
BibTeX
@article{Cortial2022,
author = {Cortial, Lucas and Boyer, Pierre-Olivier and Forget, Sylvain and Joubioux, Ronan Le and Blin, Olivier and Mouthon, Franck},
title = {Rare diseases: specific challenges for sustainable accessibility of treatments for patients},
journal = {Rare Disease and Orphan Drugs Journal},
year = {2022},
doi = {10.20517/rdodj.2022.08}
}
EUVIMED